Single-cell transcriptomic profiling reveals immune cell heterogeneity in acute myeloid leukaemia peripheral blood mononuclear cells after chemotherapy

被引:0
作者
Xuqiao Hu
Dongyan Cao
Zhenru Zhou
Zhaoyang Wang
Jieying Zeng
Wen-Xu Hong
机构
[1] Shenzhen Institute of Dermatology,Shenzhen Center for Chronic Disease Control and Prevention
[2] First Affiliated Hospital of Southern University of Science and Technology (Shenzhen People’s Hospital),Second Clinical Medical College of Jinan University
[3] the Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine,Department of Biliary
[4] Shanghai Cancer Institute,Pancreatic Surgery
[5] Shanghai Jiaotong University School of Medicine,State Key Laboratory of Oncogenes and Related Genes
来源
Cellular Oncology | 2024年 / 47卷
关键词
AML; scRNA-seq; PBMC; Monocyte; Chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:97 / 112
页数:15
相关论文
共 189 条
[1]  
Gebru MT(2020)Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia J. Hematol. Oncol. 13 155-243
[2]  
Wang HG(2016)Acute myeloid leukemia: a comprehensive review and 2016 update Blood Cancer J. 6 e441-70
[3]  
De Kouchkovsky I(2010)Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML Science 328 240-1281
[4]  
Abdul-Hay M(2020)Advances in acute myeloid leukemia: recently approved therapies and drugs in development Cancers 12 3225-611
[5]  
Zhang XW(2016)Hematopoietic stem cell transplantation for patients with AML in first complete remission Blood 127 62-526
[6]  
Yan XJ(2019)Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity Cell 176 1265-802
[7]  
Zhou ZR(2019)Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation Nat. Med. 25 603-1137
[8]  
Stanchina M(2019)A general approach for detecting expressed mutations in AML cells using single cell RNA-sequencing Nat. Commun. 10 3660-1167
[9]  
Soong D(2017)Arsenic trioxide degrades NPM-ALK fusion protein and inhibits growth of ALK-positive anaplastic large cell lymphoma Leukemia 31 522-272
[10]  
Zheng-Lin B(2018)The emerging role of immune checkpoint based approaches in AML and MDS Leuk. Lymphoma 59 790-371